236 related articles for article (PubMed ID: 29774520)
1. Implantation of bioresorbable scaffolds under guidance of optical coherence tomography: Feasibility and pilot clinical results of a systematic protocol.
Gutiérrez-Chico JL; Cortés C; Schincariol M; Limon U; Yalcinli M; Durán-Cortés MA; Jaguszewski M
Cardiol J; 2018; 25(4):443-458. PubMed ID: 29774520
[TBL] [Abstract][Full Text] [Related]
2. Impact of strut thickness on acute mechanical performance: A comparison study using optical coherence tomography between DESolve 150 and DESolve 100.
Boeder NF; Dörr O; Bauer T; Mattesini A; Elsässer A; Liebetrau C; Achenbach S; Hamm CW; Nef HM
Int J Cardiol; 2017 Nov; 246():74-79. PubMed ID: 28579164
[TBL] [Abstract][Full Text] [Related]
3. Optical coherence tomography guidance for percutaneous coronary intervention with bioresorbable scaffolds.
Caiazzo G; Longo G; Giavarini A; Kilic ID; Fabris E; Serdoz R; Mattesini A; Foin N; Secco GG; De Rosa S; Indolfi C; Di Mario C
Int J Cardiol; 2016 Oct; 221():352-8. PubMed ID: 27404705
[TBL] [Abstract][Full Text] [Related]
4. Effect of Post-Dilatation Following Primary PCI With Everolimus-Eluting Bioresorbable Scaffold Versus Everolimus-Eluting Metallic Stent Implantation: An Angiographic and Optical Coherence Tomography TROFI II Substudy.
Yamaji K; Brugaletta S; Sabaté M; Iñiguez A; Jensen LO; Cequier A; Hofma SH; Christiansen EH; Suttorp M; van Es GA; Sotomi Y; Onuma Y; Serruys PW; Windecker S; Räber L
JACC Cardiovasc Interv; 2017 Sep; 10(18):1867-1877. PubMed ID: 28935079
[TBL] [Abstract][Full Text] [Related]
5. Optical Coherence Tomography- Versus Angiography-Guided Magnesium Bioresorbable Scaffold Implantation in NSTEMI Patients.
Fallesen CO; Antonsen L; Maehara A; Noori M; Hougaard M; Hansen KN; Ellert J; Ahlehoff O; Veien KT; Lassen JF; Junker AB; Hansen HS; Jensen LO
Cardiovasc Revasc Med; 2022 Jul; 40():101-110. PubMed ID: 34949544
[TBL] [Abstract][Full Text] [Related]
6. Second generation, sirolimus-eluting, bioresorbable Tyrocore scaffold implantation in patients with ST-segment elevation myocardial infarction: Baseline OCT and 30-day clinical outcomes - A FANTOM STEMI pilot study.
Koltowski L; Tomaniak M; Ochijewicz D; Maksym J; Roleder T; Zaleska M; Proniewska K; Opolski G; Kochman J
Catheter Cardiovasc Interv; 2020 Jul; 96(1):E1-E7. PubMed ID: 31343827
[TBL] [Abstract][Full Text] [Related]
7. Comparison of acute expansion of bioresorbable vascular scaffolds versus metallic drug-eluting stents in different degrees of calcification: An Optical Coherence Tomography Study.
Ming Fam J; van Der Sijde JN; Karanasos A; Felix C; Diletti R; van Mieghem N; de Jaegere P; Zijlstra F; Jan van Geuns R; Regar E
Catheter Cardiovasc Interv; 2017 Apr; 89(5):798-810. PubMed ID: 27717119
[TBL] [Abstract][Full Text] [Related]
8. Post-dilatation after implantation of bioresorbable everolimus- and novolimus-eluting scaffolds: an observational optical coherence tomography study of acute mechanical effects.
Blachutzik F; Boeder N; Wiebe J; Mattesini A; Dörr O; Most A; Bauer T; Röther J; Tröbs M; Schlundt C; Achenbach S; Hamm CW; Nef HM
Clin Res Cardiol; 2017 Apr; 106(4):271-279. PubMed ID: 27757522
[TBL] [Abstract][Full Text] [Related]
9. Optical coherence tomography-guided versus angiography-guided implantation of everolimus-eluting bioresorbable vascular scaffolds: Comparison of coverage, apposition and clinical outcome. The ALSTER-OCT ABSORB registry.
Heeger CH; Schedifka AS; Meincke F; Spangenberg T; Wienemann H; Kreidel F; Kuck KH; Ghanem A; Bergmann MW
Cardiol J; 2018; 25(4):459-469. PubMed ID: 29512092
[TBL] [Abstract][Full Text] [Related]
10. Serial Baseline, 12-, 24-, and 60-Month Optical Coherence Tomography Evaluation of ST Segment Elevation Myocardial Infarction Patients Treated with Absorb Bioresorbable Vascular Scaffold.
Koltowski L; Tomaniak M; Ochijewicz D; Zieliński K; Proniewska K; Malinowski KP; Zaleska M; Maksym J; Roleder T; Partyka L; Kochman W; Filipiak KJ; Opolski G; Kochman J
Am J Cardiol; 2021 Sep; 155():23-31. PubMed ID: 34315572
[TBL] [Abstract][Full Text] [Related]
11. Optical coherence tomography in STEMI with bioresorbable scaffold: possible cause of coronary flow impairment? A sub-study from the Prague 19 trial.
Loffi M; Tousek P; Budesinsky T; Lisa L; Santangelo A; Widimsky P; Kocka V
Heart Vessels; 2018 Nov; 33(11):1282-1287. PubMed ID: 29777297
[TBL] [Abstract][Full Text] [Related]
12. Complex bifurcation lesions: Randomized comparison of a fully bioresorbable modified t stenting strategy versus bifurcation reconstruction with a dedicated self-expanding stent in combination with bioresorbable scaffolds, an OCT study: Rationale and design of the COBRA II trial.
Bennett J; Adriaenssens T; Desmet W; Dubois C
Catheter Cardiovasc Interv; 2016 Nov; 88(6):843-853. PubMed ID: 27184586
[TBL] [Abstract][Full Text] [Related]
13. Bioresorbable vascular scaffolds in coronary chronic total occlusions revascularization: safety assessment related to struts coverage and apposition in 6-month OCT follow-up.
Abellas-Sequeiros RA; Ocaranza-Sanchez R; Trillo-Nouche R; Gonzalez-Juanatey C; Gonzalez-Juanatey JR
Heart Vessels; 2017 Sep; 32(9):1077-1084. PubMed ID: 28432385
[TBL] [Abstract][Full Text] [Related]
14. Preliminary Report of Clinical Outcomes After Single Crossover Bioresorbable Scaffold Implantation Without Routine Side Branch Strut Dilation.
Tanaka A; Jabbour RJ; Kawamoto H; Mangieri A; Pagnesi M; Montalto C; Chieffo A; Carlino M; Montorfano M; Latib A; Colombo A
Catheter Cardiovasc Interv; 2016 Nov; 88(6):865-870. PubMed ID: 27219102
[TBL] [Abstract][Full Text] [Related]
15. Procedural findings and early healing response after implantation of a self-apposing bioresorbable scaffold in coronary bifurcation lesions.
Holck EN; Fox-Maule C; Barkholt TØ; Jakobsen L; Tu S; Maeng M; Dijkstra J; Christiansen EH; Holm NR
Int J Cardiovasc Imaging; 2019 Jul; 35(7):1199-1210. PubMed ID: 31053981
[TBL] [Abstract][Full Text] [Related]
16. A 12-month angiographic and optical coherence tomography follow-up after bioresorbable vascular scaffold implantation in patients with ST-segment elevation myocardial infarction.
Kochman J; Tomaniak M; Kołtowski Ł; Jąkała J; Proniewska K; Legutko J; Roleder T; Pietrasik A; Rdzanek A; Kochman W; Brugaletta S; Kaluza GL
Catheter Cardiovasc Interv; 2015 Oct; 86(4):E180-9. PubMed ID: 26015294
[TBL] [Abstract][Full Text] [Related]
17. Neointimal coverage and late apposition of everolimus-eluting bioresorbable scaffolds implanted in the acute phase of myocardial infarction: OCT data from the PRAGUE-19 study.
Toušek P; Kočka V; Malý M; Lisa L; Buděšínský T; Widimský P
Heart Vessels; 2016 Jun; 31(6):841-5. PubMed ID: 25896128
[TBL] [Abstract][Full Text] [Related]
18. Expansion in calcific lesions and overall clinical outcomes following bioresorbable scaffold implantation optimized with intravascular ultrasound.
Kawamoto H; Ruparelia N; Latib A; Miyazaki T; Sato K; Tanaka A; Naganuma T; Sticchi A; Chieffo A; Carlino M; Montorfano M; Colombo A
Catheter Cardiovasc Interv; 2017 Apr; 89(5):789-797. PubMed ID: 27545845
[TBL] [Abstract][Full Text] [Related]
19. Bioresorbable everolimus-eluting vascular scaffold in patients with ST-segment elevation myocardial infarction: Optical coherence tomography evaluation and clinical outcomes.
Kochman J; Tomaniak M; Pietrasik A; Kołtowski Ł; Rdzanek A; Huczek Z; Mazurek T; Jąkała J; Ząbek A; Legutko J; Kochman W; Filipiak KJ
Cardiol J; 2015; 22(3):315-22. PubMed ID: 25428734
[TBL] [Abstract][Full Text] [Related]
20. Coronary Artery Aneurysm After Bioresorbable Scaffold Implantation in a Woman With an Acute Coronary Syndrome.
Cereda AF; Canova PA; Oreglia JA; Soriano FS
J Invasive Cardiol; 2017 Jul; 29(7):E77-E78. PubMed ID: 28667808
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]